NEW YORK – Researchers at Massachusetts General Hospital, Color, and elsewhere have determined that polygenic factors can significantly modify the risk conferred by monogenic risk variants for breast cancer, colon cancer, or coronary artery disease, and are exploring the best ways to implement a combined monogenic/polygenic risk score into patient care.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.